About Aeviant
Aeviant Biosciences is a private, independent and founder-led biosciences company based in British Columbia, Canada.
Aeviant was incorporated in April 2026. It was founded to investigate whether a drug can restore endogenous regulation where a pathological system is chronically overactive, rather than impose the same pharmacological activity across healthy and pathological states.
Aeviant works from a physiology-led view of selectivity: target preference is considered alongside biological state, timing, endogenous demand and functional consequence. This is a way to frame research, not a validated or repeatable discovery system.
Work to date is founder-led and computational. Aeviant has not published experimental, in vivo or translational results. Chemistry and biological testing require capabilities that are not currently internal.
Read more about Aeviant’s approach and lead public program.
Last reviewed .